Investor Presentaiton slide image

Investor Presentaiton

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW (in thousands) (unaudited) CASH FLOW FROM OPERATING ACTIVITIES: Net loss Adjustments to reconcile net loss to cash (used in) provided by operating activities Non-cash income and expense adjustments, net Changes in assets and liabilities (1) Net cash (used in) provided by operating activities CASH FLOW FROM INVESTING ACTIVITIES: Acquisition of property and equipment (1) Year Ended December 31, 2021 December 31, 2020 (29,925) $ (7,589) 16,149 35,587 6,203 23,383 (7,573) 51,381 (9,439) (5,427) Purchases of debt and equity investments (3,156) (5,750) Proceeds from sale of property and equipment 2,725 Distributions in excess of earnings from Affiliates Insurance Company 11 287 Proceeds from sale of debt and equity investments 4,934 10,408 Net cash (used in) provided by investing activities (7,650) 2,243 CASH FLOW FROM FINANCING ACTIVITIES: Costs related to issuance of common stock Repayments of mortgage note payable Repayments of finance lease principal Payment of employee tax obligations on withheld shares Net cash used in financing activities (559) (414) (387) (807) (214) (60) (1,435) (1,006) (Decrease) increase in cash and cash equivalents and restricted cash and restricted cash equivalents Cash and cash equivalents and restricted cash and restricted cash equivalents at beginning of period Cash and cash equivalents and restricted cash and restricted cash equivalents at end of period (16,658) 52,618 109,597 56,979 $ 92,939 $ 109,597 Reconciliation of cash and cash equivalents and restricted cash and cash equivalents: Cash and cash equivalents Current restricted cash and cash equivalents Other restricted cash and cash equivalents 66,987 24,970 982 $ 84,351 23,877 1,369 Cash and cash equivalents and restricted cash and cash equivalents at end of period $ 92,939 $ 109,597 (1) Changes in assets and liabilities and acquisition of property and equipment for the year ended December 31, 2020. reflect reclassification adjustments of certain DHC reimbursements from the prior period to conform to the current period presentation. Appendix 18
View entire presentation